APPLICATIONS PUBLISHED 9 OCTOBER 2002
Published: 1-Apr-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T:+43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T:+43 1521 260 F +43 1 52126 4492
Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
The Ohio State University 1246597*
Oral use of dehydroepiandrosterone and some of its derivatives as pigmentation regulators
Assistance Publique, Hopitaux de Paris 1246603*
Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of skin
Assistance Publique, Hopitaux de Paris 1246604*
Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow
Board of Regents The University of Texas System 1246605*
Iron chelator delivery system
Gwathmey, Judith 1245506*
Proteoliposomes containing an integral membrane protein having one or more transmembrane domains
Dana-Farber Cancer Institute 1246607*
Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
Imarx Therapeutics 1246608*
Micronised freeze-dried particles
Brown University Research Foundation 1246609*
Instant granules and process for their formulation
Dr Gargely & Co 1246610*
Formulations of active components in the form of a solid dispersion
Knoll 1246611*
Osmotic device containing pseudoephedrine and an H1 antagonist
Osmotica 1246612*
Osmotic device within an osmotic device
Osmotica 1246613*
Osmotic device containing venlafaxine and an anti-psychotic agent
Osmotica 1246614*
Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
Shear/Kershman Laboratories 1246615*
Cell permeable peptides for inhibition of inflammatory reactions and methods of use
Vanderbilt University 1246616*
Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumours of the central nervous system
Rhode Island Hospital 1246617*
N, N'-bis(2-hydroxybenzyl)ethylenediamine-N, N'-diacetic acid in iron chelating therapy
University of Florida Research Foundation 1246618*
Urotensin-II receptor antagonists
SmithKline Beecham 1246619*
Substituted acylhydroxamic acids and method of reducing TNF-G(A) levels
Celgene 1246620*
Nitrostated and nitrosylated cyclooxygenase-2 inhibitors, compsns and methods of use
Nitromed 1246621*
Novel substituted benzimidazole dosage forms and method of using the same
The Curators of the University of Missouri 1246622*
Compounds specific to adenosine A1, A2A and A3 receptors and uses thereof
OSI Pharmaceuticals 1246623*
Triazine compounds for treating diseases resulting from infestation with parasitic protozoans
Bayer 1246624*
Methods and compsns for mitigating pain using nitrate esters
Queen's University at Kingston 1246625*
Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance
Danisco 1246626*
Polyanhydrides with biologically active degradation products
Rutgers, the State University of New York 1246627*
Physiologically balanced, ionised, acidic solution and methodology for use in wound healing
Novacal Pharmaceuticals 1246628*
Methods of using electron active compounds for managing cancer
Marantech Holding 1246629*
Compounds and methods for facilitating skin growth and managing skin conditions
Marantech Holding 1246630*
Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substance mixtures
Teraklin 1246631*
Catechins and green tea extract for the treatment of amyloidosis in Alzheimer's disease and other amyloidoses
Proteotech 1246632*
Method for extracting unsaponifiable matters from vegetable oils using chloro-1-butane, compsn containing said unsaponifiable matters
Laboratoires Pharmascience 1246633*
Methods for treating pancreatic disorders
Allergan Sales 1246634*
O-superfamily conotoxin peptides
The University of Utah Research Foundation; Cognetix 1246635*
Molecules that influence pathogen resistance
The Government of the United States of America, as represented by The Secretary of Health and Human Services 1246636*
Methods of modulation of the immune system
The Hospital for Sick Children 1246637*
Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
Amylin Pharmaceuticals 1246638*
GLP-2 formulations
NPS Allelix 1246639*
Method and compsn for treatment and/or prevention of antibiotic-resistant microorganism infections
Sa Majeste la Reine du Chef du Canada Agriculture; et Agroalimentaire Canada, Centre de Recherche et Developpement sur le bovin laitier et le Porc 1246640*
The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
New Horizons Diagnostics 1246641*
Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularisation
Aventis Pharma 1246642*
DNA vaccines encoding antigen linked to a domain that binds CD40
Ledbetter, Jeffrey A; Hayden-Ledbetter, Martha S 1246643*
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compsns
Epimmune 1246644*
A stable immunogenic compsn for frozen storage
Aphton Corp 1246645*
Enhancing the immune response to an antigen by presensitising with an inducing agent prior to immunising with the inducing agent and the antigen
Aventis Pasteur 1246646*
Non-immunosupressant HIV TAT
Inist 1246647*
Dendrimer-photosensitiser complexes for medical applications
Biolitec 1246648*
Intravascular delivery of nucleic acid
Mirus Corp 1246649*
Flexible chitosan film for wound dressings
Kordestani, Soheila Salashoor 1246650*
Racemic and optically pure metabolites of sibutramine, their preparation, compsns comprising them and their use as dopamine uptake inhibitors
Sepracor 1246789*
Substituted 1 and 2 naphthol mannich bases
Gruenenthal 1246790*
Aminomethyl-phenyl-cyclohexanone derivatives
Gruenenthal 1246791*
Compounds and compsns for delivering active agents
Emisphere Technologies 1246792*
Substituted aminomethyl-phenyl-cyclohexane derivatives
Gruenenthal 1246793*
Process and intermediates for preparing a cyclohexylnitrile
SmithKline Beecham 1246794*
Process for the preparation of diphenyl ether compounds
Syngenta 1246796*
Cyclopentyl sulphonamide derivatives
Eli Lilly 1246797*
Process for the production of N-methyl pyrrolidine using gamma butyrolactine and mixed methylamines as starting materials
BASF 1246798*
Substituted pyrrole mannich bases to combat pain and allergic reactions
Gruenenthal 1246799*
Beta-amino acid compounds as integrin antagonists
Bayer 1246800*
Methods for the synthesis of alfentanil, sufentanil and remifentanil
Mallinckrodt 1246801*
